The New York Times is assessing the progress in development of potential drug treatments for covid-19, and ranking them for effectiveness and safety.
Race Against the Virus: Hunt for a Vaccine is a Channel 4 documentary which tells the story of the coronavirus pandemic through the eyes of the scientists on the frontline. Panorama: The Race for a Vaccine is a BBC documentary about the inside story of the development of the Oxford/AstraZeneca vaccine against covid-19. Why Is Covid Killing People of Colour? is a BBC documentary, which investigates what the high covid-19 death rates in ethnic minority patients reveal about health inequality in the UK. The first episode examines the origins of the covid-19 pandemic. The Jump is a BBC Radio 4 series exploring how viruses can cross from animals into humans to cause pandemics. Our podcast sees expert journalists from the magazine discuss the biggest science stories to hit the headlines each week – from technology and space, to health and the environment. New Scientist Weekly features updates and analysis on the latest developments in the covid-19 pandemic. What to read, watch and listen to about coronavirus What’s the fairest way to share covid-19 vaccines around the world? Long covid: Do I have it, how long will it last and can we treat it? Where did coronavirus come from? And other covid-19 questions answeredĬovid-19 vaccines: Everything you need to know about the leading shots Proof of vaccination and a recent negative covid-19 test are now required to enter the US. The ban, covering the UK, much of Europe, China and India, has been in place since early 2020. Restrictions on travelling to the US from 33 countries have been lifted today. Trials have shown that it halves the risk of unvaccinated people needing hospital treatment or dying, and further trials are needed to see how it works in the vaccinated population, Hopkins said. Molnupiravir, developed by Merck and Ridgeback Biotherapeutics, was approved by the UK medicines regulator last week. The UK will begin rolling out the covid-19 antiviral drug molnupiravir in a clinical trial later this month, Susan Hopkins at the UK Health Security Agency has said. “It is particularly the older age groups, so the over-70s in particular, but also those who are clinically vulnerable, extremely vulnerable, and have underlying medical conditions,” she said. Deaths from covid-19 are increasingly occurring in vaccinated people, because of immunity waning over time, said Susan Hopkins, chief medical adviser at the UK Health Security Agency.
0 kommentar(er)
